Medicus Pharma Ltd. Common Stock (MDCX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 26.32K | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | -26.32K | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 100% | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 6.27M | 7.79M | 15.43M | 6.02M | 5.13M | 2.35M | 2.98M | 4.04M | 1.78M | 1.82M | 226.81K | 255.69K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 5.89M | 5.2M | 5.02M | 4.58M | 3.12M | 1.06M | 2.2M | 2.95M | 1.44M | 1.79M | 186.42K | 206.12K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.7M | 2.59M | 10.4M | 1.44M | 2.01M | 1.37M | 777.51K | 1.07M | 316.39K | 34.49K | 40.39K | 49.58K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | -78.39K | 0 | 26.11K | 26.04K | 0 | 0 | 0 |
| Operating Income | -6.27M | -7.79M | -15.43M | -6.02M | -5.13M | -2.35M | -3.01M | -4.04M | -1.78M | -1.82M | -226.81K | -255.69K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -22.26% | -231.42% | -413.23% | -48.84% | -187.59% | -29.06% | -1225.21% | -1480.77% | - | - | - | - |
| EBITDA | -6.27M | -7.79M | -15.43M | -6.02M | -5.1M | -1.48M | -2.98M | -4.02M | -1.76M | -2.54M | -2.66M | -246.75K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -22.83% | -426.94% | -417.76% | -49.81% | -190.47% | 41.84% | -12.13% | -1527.55% | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 26.32K | 26.03K | 25.92K | 0 | 0 | 8.95K |
| EBIT | -6.27M | -7.79M | -15.43M | -6.02M | -5.1M | -1.48M | -2.95M | -4.04M | -1.78M | -2.54M | -2.66M | -246.75K |
| Net Interest Income | 374.71K | -195.66K | 11.57K | 40K | 23.87K | -747.21K | 46.53K | -88.26K | -9.01K | 0 | -306.48K | -385.79K |
| Interest Income | 0 | 0 | 11.57K | 40K | 23.87K | 48.9K | 55.51K | 0 | 0 | 0 | 0 | -143.86K |
| Interest Expense | -374.71K | 195.66K | 0 | 0 | 0 | 796.11K | 8.98K | 88.26K | 9.01K | 0 | 306.48K | 241.92K |
| Other Income/Expense | -324.58K | -393.96K | -554.97K | -160K | 23.87K | 76.12K | 46.53K | -88.18K | -9.01K | -720.8K | -2.74M | -232.97K |
| Pretax Income | -6.59M | -8.18M | -15.98M | -6.18M | -5.1M | -2.27M | -2.96M | -4.13M | -1.79M | -2.54M | -2.96M | -488.67K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.59M | -8.18M | -15.98M | -6.18M | -5.1M | -2.27M | -2.96M | -4.13M | -1.79M | -2.54M | -2.96M | -488.67K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -29.19% | -259.82% | -440.05% | -49.53% | -184.81% | 10.53% | 0.15% | -745.19% | - | - | - | - |
| Net Income (Continuing) | -6.59M | -8.18M | -15.98M | -6.18M | -5.1M | -2.27M | -2.96M | -4.13M | -1.79M | -2.54M | -2.96M | -488.67K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 101.84K | 76.5K | 105.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.22 | -0.43 | -1.12 | -0.43 | -0.42 | -0.24 | -0.31 | -0.51 | -0.22 | -1.41 | -0.59 | -0.06 |
| EPS Growth % | 47.62% | -79.17% | -261.29% | 15.69% | -90.91% | 82.98% | 47.46% | -740.2% | - | - | - | - |
| EPS (Basic) | -0.22 | -0.43 | -1.12 | -0.43 | -0.42 | -0.24 | -0.31 | -0.51 | -0.22 | -1.41 | -1.47 | -0.06 |
| Diluted Shares Outstanding | 29.54M | 25.18M | 18.63M | 14.28M | 12.24M | 9.51M | 9.51M | 8.17M | 8.08M | 2.02M | 5.03M | 8.05M |
| Basic Shares Outstanding | 29.54M | 25.18M | 18.63M | 14.28M | 12.24M | 9.51M | 9.51M | 8.17M | 8.08M | 2.02M | 2.02M | 8.05M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |